BELLUS Health Inc.
NASDAQ: BLU0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Roberto Francesco Bellini
- Employees
- 74
- Headquarters
- Laval, Canada
- IPO year
- 2000
- Market cap
- $1.9B
- Website
- https://www.bellushealth.com
Loading BLU…
Loading profile data…Frequently asked questions about BLU
What does BELLUS Health Inc. (BLU) do?
BELLUS Health Inc. is a clinical-stage biopharmaceutical company headquartered in Laval, Canada, and founded in 1993. The firm focuses on developing therapeutic solutions for refractory chronic cough (RCC) and other related cough hypersensitivity conditions. Its leading product candidate, BLU-5937, an antagonist designed to block the P2X3 recept...
Where does BLU trade?
BELLUS Health Inc. (BLU) trades on the NASDAQ Global Select.
What sector is BLU in?
BELLUS Health Inc. (BLU) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BELLUS Health Inc.?
Roberto Francesco Bellini is the chief executive officer of BELLUS Health Inc. (BLU).
Where is BELLUS Health Inc. headquartered?
BELLUS Health Inc. is headquartered in Canada.
Does BLU pay a dividend?
BELLUS Health Inc. (BLU) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BLU go public?
BELLUS Health Inc. (BLU) completed its initial public offering in 2000.